Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Sunrise Realty Trust M&A Deal with Southern Realty Trust Inc.
Sunrise Realty Trust stockholders approved the issuance of approximately 8.46 million shares for its pending merger with Southern Realty Trust Inc. The merger, which has now received approval from both companies' stockholders, is expected to close on November 5, 2026, creating a larger Nasdaq-listed commercial real estate lending platform.
Stem, Inc. received a non-compliance letter from the NYSE because its average global market capitalization and stockholders' equity both fell below the $50 million minimum requirement over a 30 trading-day period. The company intends to submit a business plan within 45 days detailing how it will regain compliance within the 18-month cure period. The company's common stock will continue to trade on the NYSE during this period, subject to the exchange's acceptance of the plan.
Ms. Helen Nolan, a Non-Executive Director of Dole plc, has informed the company of her intention to retire from the Board of Directors effective December 31, 2026. Ms. Nolan has served on the board since 2021, and her departure appears to be a planned retirement.
Akebia Therapeutics received a deficiency notice from Nasdaq because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 19, 2027, to regain compliance, which requires the stock to close at $1.00 or higher for at least 10 consecutive business days. Akebia is evaluating options to cure the deficiency, including a potential reverse stock split.
MacroGenics announced positive interim Phase 1 data for MGC026, a B7-H3-directed antibody-drug conjugate, in patients with advanced solid tumors. The study showed a 27% best overall response rate in heavily pretreated SCCHN patients and a manageable safety profile with no treatment-related discontinuations in that cohort. Based on these results, the company plans to initiate a front-line combination study evaluating MGC026 with pembrolizumab.
Marvell Technology $3B Debt Financing with Bank of America, N.A.
Marvell Technology entered into a $3 billion Third Amended and Restated Revolving Credit Agreement, doubling its previous $1.5 billion facility. The new agreement matures in October 2031 and includes an accordion feature allowing for an additional $2 billion in commitments. Proceeds will be used for working capital and general corporate purposes.
Polar Power, Inc. is providing an update on its efforts to regain compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million. The company has until October 28, 2026, to demonstrate compliance and has executed several financings, including convertible notes and Series A Preferred Stock issuances, to bolster its equity position. These transactions, along with an equity line of credit with Roth Principal Investments, are intended to meet the Nasdaq Capital Market's continued listing standards.
Sally J. Smith has notified Hormel Foods Corporation of her decision to retire from the Board of Directors, effective at the 2027 Annual Meeting of Stockholders. She will not stand for re-election, and the company stated her departure is not due to any disagreement.
Aptevo Therapeutics entered into Amendment No. 6 to its Rights Agreement, extending the expiration date of its shareholder rights plan (poison pill) to October 23, 2027. The amendment also adjusted the purchase price for the contingent preferred stock rights to $14.56 per one one-thousandth of a share.
Blue Owl Technology Income Corp. declared monthly distributions for its Class S, D, and I shares at a gross rate of $0.074775 per share, payable by November 30, 2026. The company also disclosed the sale of 505,374 unregistered Class I shares for approximately $4.98 million and reported a total net asset value of $2.6 billion as of September 30, 2026.
Agios Pharmaceuticals CMO Sarah Gheuens Sells $74.6K of Stock
Sarah Gheuens, CMO, sold 1,989 shares of Agios Pharmaceuticals, Inc. at $37.52 to $37.53 a share (average $37.53) in 2 transactions, worth $74.6K in total between Oct 21, 2026 and Oct 22, 2026. Shares held after the trade: 54,645 (-0.9%).
High Roller Technologies has commercially launched ROLR™, its real-money prediction markets platform, for eligible U.S. customers following a successful beta period. The platform offers event-based contracts through a partnership with Crypto.com | Derivatives North America (CDNA) and is expected to begin generating revenue in Q4 2026.
Counterparty
Crypto.com | Derivatives North America
“Today’s full commercial launch of our prediction markets platform is a defining milestone for High Roller as we bring ROLR to the public and begin the next phase of our growth.”
Seth Young, Chief Executive Officer of High Roller Technologies
“Our goal is to make prediction markets accessible and engaging through an intuitive customer experience, and our experience operating real-money consumer platforms provides a strong foundation for building this business.”
Seth Young, Chief Executive Officer of High Roller Technologies
Amneal Pharmaceuticals M&A Deal with Kashiv BioSciences, LLC
Amneal Pharmaceuticals filed an amendment to its previous 8-K to provide required historical financial statements and pro forma financial information following its completed acquisition of Kashiv BioSciences, LLC. The acquisition was originally completed on August 10, 2026, pursuant to a Membership Interest Purchase Agreement dated April 21, 2026.
Red Cat Holdings, through its subsidiary SMOT Acquisition GmbH, has launched a voluntary public cash tender offer to acquire all outstanding shares of Austrian engine manufacturer Steyr Motors AG for EUR 39.00 per share. The transaction is intended to strengthen Red Cat's 'Blue Ops' uncrewed surface vessel (USV) strategy by integrating Steyr's marine engine technology and European manufacturing base.
Counterparty
Steyr Motors AG
“This proposed transaction is about investing in that foundation and helping Steyr Motors grow. We see Austria as central to the future of the business, and our goal is to provide additional resources, customer access and long-term demand that can support Steyr Motors’ employees, operations and continued expansion.”
Jeff Thompson, Chief Executive Officer of Red Cat
“Four years into Steyr Motors’ transformation, I am very excited to lead its next chapter with Red Cat as strategic partner on our side. Our engineering and Red Cat’s reach into international markets are the basis for joint growth, and Red Cat stands firmly behind our site and our people.”
Travelers Companies EVP & Co-Chief Invest. Officer David Donnay Rowland Sells $2.03M of Stock
David Donnay Rowland, EVP & Co-Chief Invest. Officer, sold 5,000 shares of Travelers Companies, Inc. at $405.62 a share, worth $2.03M in total on Oct 22, 2026. Shares held after the trade: 10,479 (-32.3%).
Applied Industrial Technologies, Inc. filed an amendment to report that newly appointed director Pamela J. Tomczik has been assigned to the Board's Audit Committee and Corporate Governance & Sustainability Committee. Ms. Tomczik was originally appointed to the Board on August 11, 2026, and these committee assignments became effective on October 20, 2026.
Reliance Global Group M&A Deal with Steyr Motors AG
Red Cat Holdings announced a voluntary public purchase offer to acquire all outstanding shares of Steyr Motors AG for EUR 39.00 per share in cash. The deal is intended to strengthen Red Cat's autonomous maritime portfolio by integrating Steyr's marine engine technology and European manufacturing base.
Edgemode Debt Financing Update with Vanquish Funding Group Inc.
Edgemode, Inc. entered into a securities purchase agreement with Vanquish Funding Group Inc. for an unsecured original issue discount convertible promissory note in the principal amount of $159,600. The note carries a 15% one-time interest charge and matures on July 15, 2027, with net proceeds of $133,000 intended for working capital. The note is only convertible into common stock following an event of default and at least 180 days after issuance.
Jaclyn Hoffman resigned from her position as Chief Marketing Officer of LQR House Inc., effective October 20, 2026. The company stated that her departure was not due to any disagreement regarding operations, policies, or practices.
Myers Industries adopted an amended and restated Senior Officer Severance Plan for its executive leadership team, including CEO Aaron Schapper and CFO Samantha Rutty. The updates include adding target bonuses to cash severance calculations and increasing the change-in-control severance multiplier for the CEO from 2.5x to 3x.
Nathans Famous M&A Deal with Smithfield Foods, Inc.
Stockholders of Nathan’s Famous, Inc. approved the previously announced merger agreement with Smithfield Foods, Inc. at a special meeting held on October 23, 2026. Under the agreement, Nathan’s will become a wholly-owned subsidiary of Smithfield Foods following the completion of the merger.
BlackRock Private Credit Fund declared a regular monthly distribution of $0.1774 per share for all share classes, payable on November 25, 2026. The Fund also disclosed a net asset value (NAV) of $23.53 per share as of September 30, 2026, and reported the private sale of approximately $5.89 million in Institutional Class shares to feeder vehicles.
Peter Knag has stepped down as Chief Financial Officer of Offerpad Solutions Inc. effective October 20, 2026, and will serve as a Senior Advisor through November 30, 2026. The company appointed Andrew Pieper, its current Senior Vice President and Controller, to serve as Interim Chief Financial Officer and principal financial officer.
Travelers Companies EVP & Pres., Bond & Spec. Ins. Jeffrey P. Klenk Sells $3.66M of Stock
Jeffrey P. Klenk, EVP & Pres., Bond & Spec. Ins., sold 9,016 shares of Travelers Companies, Inc. at $405.57 a share, worth $3.66M in total on Oct 22, 2026. Shares held after the trade: 6,075 (-59.7%).
Valor Energy Inc entered into a securities purchase agreement to sell 2,145,923 shares of common stock in a private placement. The offering is expected to generate gross proceeds of approximately $5.0 million. The company intends to use the net proceeds for AI data center project development and general corporate purposes.
Ignite Aggregator LP, 10% Owner, sold 1,500,000 shares of InnovAge Holding Corp. at $9.25 a share, worth $13.9M in total on Oct 21, 2026. Shares held after the trade: 101,076,555 (-1.5%).
Palvella Therapeutics COO Kathleen Goin Sells $537K of Stock
Kathleen Goin, COO, sold 4,313 shares of Palvella Therapeutics, Inc. at $123.62 to $126.19 a share (average $124.58) in 3 transactions, worth $537K in total on Oct 21, 2026. Shares held after the trade: 0 (-100.0%).
InnovAge Holding 10% Owner Tco Group Holdings L.P. Sells $13.9M of Stock
Tco Group Holdings L.P., 10% Owner, sold 1,500,000 shares of InnovAge Holding Corp. at $9.25 a share, worth $13.9M in total on Oct 21, 2026. Shares held after the trade: 101,076,555 (-1.5%).
Blue Owl Credit Income Corp. sold 464,303 unregistered shares of Class I common stock for approximately $4.26 million in a private offering to feeder vehicles. The company also reported that its continuous public offering has raised over $22.49 billion in total consideration to date across all share classes.
For the fiscal year ended August 31, 2026, Jabil Inc. reported net revenues of $36.0 billion and net income of $1.0 billion. The company also announced a segment name change from Connected Living and Digital Commerce to Intelligent Devices and Robotics effective September 1, 2026, to reflect a strategic shift toward complex engineered solutions and automation.